Clinical And Pathological Implications Of Gstm1 And Gstt1 Gene Deletions In Sporadic Breast Cancer

There is a lack of consensus about the influence of GST M1/T1 gene deletions (DEL) on sporadic breast cancer (SBC). To evaluate the occurrence of DEL in 177 SBC cases and in 169 controls, and compare clinical and biological characteristics. A lower frequency of GSTM1 DEL was observed in mulatto women, OR=0.48 (0.24-0.98). The risk of nuclear grade 3 tumors (GN3) was lower in patients with GSTT1 DEL, OR=0.37 (0.15-0.90). DEL of at least one gene (ALOG) was associated with women who had not breastfed, OR=0.41 (0.19-0.88), and with negative hormone receptor, HR-, ORadj=2.25 (1.03-4.90). Both genes deleted (BGD) was associated with non-classic invasive ductal carcinoma (NCDC), ORadj=12.09 (1.03-142.03). Mulatto women with SBC had a lower frequency of GSTM1 DEL, while tumors differentiated were related to GSTT1 DEL. HRtumors were related with DEL ALOG, and the BGD was associated with a greater risk of NCDC. © Springer-Verlag 2008.213643Estimativa 2006 - Incidência de Câncer No Brasil - 2006 - INCA, , http://www.inca.gov.br/estimativa/2006/index.asp?link=conteudo-view. asp&ID=5, Brasil, Ministério da Saúde, [on line]. Rio de Janeiro, (accessed 19 Mar 2008)Kelsey, J.L., Breast cancer epidemiology: Summary and future directions (1993) Epidemiol Rev, 15, pp. 256-263Newman, B., Austin, M.A., Lee, M., King, M.C., Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families (1988) Proc Natl Acad Sci U S A, 85, pp. 3044-3048Peto, J., Easton, D.F., Matthews, F.E., Ford, D., Swerdlow, A.J., Cancer mortality in relatives of women with breast cancer: The OPCS study (1996) International Journal of Cancer, 65 (3), pp. 275-283. , DOI 10.1002/(SICI)1097-0215(19960126)65:3<275::AID-IJC1>3.0.CO;2-XLevy-Lahad, E., Friedman, E., Cancer risks among BRCA1 and BRCA2 mutation carriers (2007) British Journal of Cancer, 96 (1), pp. 11-15. , DOI 10.1038/sj.bjc.6603535, PII 6603535Tempfer, C., Hefler, L., Schneeberger, C., Huber, J., How valid is single nucleotide polymorphism (SNP) diagnosis for the individual risk assessment of breast cancer? (2006) Gynecological Endocrinology, 22 (3), pp. 155-159. , DOI 10.1080/09513590600629175, PII L216500R64033522Hayes, J.D., Pulford, D.J., The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance (1995) Crit Rev Biochem Mol Biol, 30, pp. 445-600Parl, F.F., Glutathione S-transferase genotypes and cancer risk (2005) Cancer Letters, 221 (2), pp. 123-129. , DOI 10.1016/j.canlet.2004.06.016Nelson, H.H., Wiencke, J.K., Christiani, D.C., Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta (1995) Carcinogenesis, 16, pp. 1243-1245Arruda, V.R., Grignolli, C.E., Goncalves, M.S., Soares, M.C., Menezes, R., Saad, S.T.O., Costa, F.F., Prevalence of homozygosity for the deleted alleles of glutathione S-transferase mu (GSTM1) and theta (GSTT1) among distinct ethnic groups from Brazil: Relevance to enviromental carcinogenesis? (1998) Clinical Genetics, 54 (3), pp. 210-214Van Der Hel, O.L., Bueno-de-Mesquita, H.B., Van Gils, C.H., Roest, M., Slothouber, B., Grobbee, D.E., Peeters, P.H.M., Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands) (2005) Cancer Causes and Control, 16 (6), pp. 675-681. , DOI 10.1007/s10552-005-1227-0Nascimento, H., Coy, C.S.R., Teori, M.T., Boin, I.F.S.F., Goes, J.R.N., Costa, F.F., Lima, C.S.P., Possible influence of glutathione S-transferase GSTT1 null genotype on age of onset of sporadic colorectal adenocarcinoma (2003) Diseases of the Colon and Rectum, 46 (4), pp. 510-515. , DOI 10.1007/s10350-004-6591-4Lourenco, G.J., Ortega, M.M., Nascimento, H., Teori, M.T., De Souza, C.A., Costa, F.F., Lima, C.S.P., Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia [2] (2005) European Journal of Haematology, 75 (6), pp. 530-531. , DOI 10.1111/j.1600-0609.2005.00567.xGoloni-Bertollo, E.M., Biselli, J.M., Correa, L.C., Evaluation of the influence of GSTT1 and GSTM1 null genotypes in head and neck carcinogenesis (2006) Rev Assoc Med Bras, 52, pp. 365-368Raimondi, S., Paracchini, V., Autrup, H., Barros-Dios, J.M., Benhamou, S., Boffetta, P., Cote, M.L., Taioli, E., Meta- and pooled analysis of GSTT1 and lung cancer: A HuGE-GSEC review (2006) American Journal of Epidemiology, 164 (11), pp. 1027-1042. , DOI 10.1093/aje/kwj321Sull, J.W., Ohrr, H., Kang, D.R., Nam, C.M., Glutathione S-transferase M1 status and breast cancer risk: A meta-analysis (2004) Yonsei Medical Journal, 45 (4), pp. 683-689Curran, J.E., Weinstein, S.R., Griffiths, L.R., Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility (2000) Cancer Letters, 153 (1-2), pp. 113-120. , DOI 10.1016/S0304-3835(00)00361-X, PII S030438350000361XMillikan, R., Pittman, G., Tse, C.-K., Savitz, D.A., Newman, B., Bell, D., Glutathione S-transferases M1, T1, and P1 and breast cancer (2000) Cancer Epidemiology Biomarkers and Prevention, 9 (6), pp. 567-573Ambrosone, C.B., Sweeney, C., Coles, B.F., Thompson, P.A., McClure, G.Y., Korourian, S., Fares, M.Y., Hutchins, L.F., Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer (2001) Cancer Research, 61 (19), pp. 7130-7135Gudmundsdottir, K., Tryggvadottir, L., Eyfjord, J.E., GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene (2001) Cancer Epidemiology Biomarkers and Prevention, 10 (11), pp. 1169-1173Krajinovic, M., Ghadirian, P., Richer, C., Sinnett, H., Gandini, S., Perret, C., Lacroix, A., Sinnett, D., Genetic susceptibility to breast cancer in French-Canadians: Role of carcinogen-metabolizing enzymes and gene-environment interactions (2001) International Journal of Cancer, 92 (2), pp. 220-225. , DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1184>3.0.CO;2-HMitrunen, K., Jourenkova, N., Kataja, V., Eskelinen, M., Kosma, V.-M., Benhamou, S., Vainio, H., Hirvonen, A., Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer (2001) Cancer Epidemiology Biomarkers and Prevention, 10 (3), pp. 229-236Da Fonte De Amorim, L.M., Rossini, A., Mendonca, G.A.S., Lotsch, P.F., De Almeida Simao, T., De Moura Gallo, C.V., Pinto, L.F.R., CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women (2002) Cancer Letters, 181 (2), pp. 179-186. , DOI 10.1016/S0304-3835(02)00058-7, PII S0304383502000587Zheng, W., Wen, W.-Q., Gustafson, D.R., Gross, M., Cerhan, J.R., Folsom, A.R., GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk (2002) Breast Cancer Research and Treatment, 74 (1), pp. 9-16. , DOI 10.1023/A:1016005100958Roodi, N., Dupont, W.D., Moore, J.H., Parl, F.F., Association of homozygous Wild-Type Glutathione S-Transferase M1 Genotype with Increased Breast Cancer Risk (2004) Cancer Research, 64 (4), pp. 1233-1236. , DOI 10.1158/0008-5472.CAN-03-2861Vogl, F.D., Taioli, E., Maugard, C., Zheng, W., Ribeiro Pinto, L.F., Ambrosone, C., Parl, F.F., Boffetta, P., Glutathione S-transferases M1, T1, and P1 and breast cancer: A pooled analysis (2004) Cancer Epidemiology Biomarkers and Prevention, 13 (9), pp. 1473-1479Zheng, T., Holford, T.R., Zahm, S.H., Owens, P.H., Boyle, P., Zhang, Y., Wise Sr., J.P., Ali-Osman, F., Cigarette smoking, glutathione-S-transferase M1 and T1 genetic polymorphisms, and breast cancer risk (United States) (2002) Cancer Causes and Control, 13 (7), pp. 637-645. , DOI 10.1023/A:1019500109267Zheng, T., Holford, T.R., Zahm, S.H., Owens, P.H., Boyle, P., Zhang, Y., Zhang, B., Ali-Osman, F., Glutathione S-transferase MI and TI genetic polymorphisms, alcohol consumption and breast cancer risk (2003) British Journal of Cancer, 88 (1), pp. 58-62. , DOI 10.1038/sj.bjc.6600708Park, S.-K., Kang, D., Noh, D.-Y., Lee, K.-M., Kim, S.-U., Choi, J.-Y., Choi, I.-M., Yoo, K.-Y., Reproductive factors, glutathione S-transferase M1 and T1 genetic polymorphism and breast cancer risk (2003) Breast Cancer Research and Treatment, 78 (1), pp. 89-96. , DOI 10.1023/A:1022113713226Comstock, K.E., Sanderson, B.J.S., Claflin, G., Henner, W.D., GST1 gene deletion determined by polymerase chain reaction (1990) Nucleic Acids Research, 18 (12), p. 3670Pemble, S., Schroeder, K.R., Spencer, S.R., Meyer, D.J., Hallier, E., Bolt, H.M., Ketterer, B., Taylor, J.B., Human glutathione S-transferase Theta (GSTT1): CDNA cloning and the characterization of a genetic polymorphism (1994) Biochemical Journal, 300 (1), pp. 271-276Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B., Erlich, H.A., Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase (1988) Science, 239 (4839), pp. 487-491Board, P.G., Baker, R.T., Chelvanayagam, G., Jermiin, L.S., Zeta, a novel class of glutathione transferases in a range of species from plants to humans (1997) Biochemical Journal, 328 (3), pp. 929-935Lizard-Nacol, S., Coudert, B., Colosetti, P., Riedinger, J.-M., Fargeot, P., Brunet-Lecomte, P., Glutathione S-transferase M1 null genotype: Lack of association with tumour characteristics and survival in advanced breast cancer (1999) Breast Cancer Research, 1 (1), pp. 81-87. , DOI 10.1186/bcr17Landi, S., Mammalian class theta GST and differential susceptibility to carcinogens: A review (2000) Mutat Res, 463, pp. 247-283Chacko, P., Joseph, T., Mathew, B.S., Rajan, B., Pillai, M.R., Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome (2005) Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 581 (1-2), pp. 153-163. , DOI 10.1016/j.mrgentox.2004.11.018Pike, M.C., Krailo, M.D., Henderson, B.E., 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer (1983) Nature, 303 (5920), pp. 767-770Russo, J., Russo, I.H., Biology of disease. Biological and molecular bases of mammary carcinogenesis (1987) Laboratory Investigation, 57 (2), pp. 112-137Hardy, E.E., Pinotti, J.A., Osis, M.J., Faundes, A., Reproductive variables and risk of breast cancer: A case-control study carried out in Brazil (1993) Bol Oficina Sanit Panam, 115, pp. 93-102Ries, L.A.G., Melbert, D., Krapcho, M., SEER Cancer Statistics Review, 1975-2004, , http://seer.cancer.gov/statfacts/html/breast.html?statfacts-page=breast. html&x=14&y=16, National Cancer Institute. Bethesda, MD, (accessed 19 Mar 2008)Singletary, S.E., Rating the risk factors for breast cancer (2003) Annals of Surgery, 237 (4), pp. 474-482. , DOI 10.1097/00000658-200304000-00007Maxwell, G.L., Risinger, J.I., Racial disparities research: It's not just black and white (2006) Gynecol Oncol, 101, pp. 194-197Kelley, M.K., Engqvist-Goldstein, A., Montali, J.A., Wheatley, J.B., Schmidt Jr., D.E., Kauvar, L.M., Variability of glutathione Stransferase isoenzyme patterns in matched normal and cancer human breast tissue (1994) Biochem J, 304 (PART 3), pp. 843-848Yang, G., Shu, X.-O., Ruan, Z.-X., Cai, Q.-Y., Jin, F., Gao, Y.-T., Zheng, W., Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma (2005) Cancer, 103 (1), pp. 52-58. , DOI 10.1002/cncr.20729Perquin, M., Oster, T., Maul, A., Froment, N., Untereiner, M., Bagrel, D., The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features (2001) Journal of Cancer Research and Clinical Oncology, 127 (6), pp. 368-374. , DOI 10.1007/s00432000022